Elevated syringe borrowing among men who have sex with men: A prospective study

Journal of Acquired Immune Deficiency Syndromes

Volumn 46, Issue 2, 2007, Pages 248-252

  Marshall, Brandon D L ^a,b   Wood, Evan ^a,b   Li, Kathy ^a   Kerr, Thomas ^a,b,c  

^a ST PAUL S HOSPITAL   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c BRITISH COLUMBIA CENTRE FOR EXCELLENCE IN HIV AIDS   (Canada)

Author keywords

HIV infection; Injection drug use; Men who have sex with men; Sexual partners; Syringe sharing

Indexed keywords

ADULT; ARTICLE; CANADA; CONFIDENCE INTERVAL; CONTROLLED STUDY; DRUG USE; HIGH RISK BEHAVIOR; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SEXUAL BEHAVIOR; SEXUALITY; SYRINGE;

ADULT; BRITISH COLUMBIA; COHORT STUDIES; HIV INFECTIONS; HOMOSEXUALITY, MALE; HUMANS; MALE; MULTIVARIATE ANALYSIS; NEEDLE SHARING; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SUBSTANCE ABUSE, INTRAVENOUS; URBAN POPULATION;

EID: 34748876584     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e31814a5533     Document Type: Article

References (35)

1. Hope VD, Rogers PA, Jordan L, et al. Sustained increase in the sharing of needles and syringes among drug users in England and Wales. AIDS. 2002;16:2494-2496.
2. Patrick DM, Strathdee SA, Archibald CP, et al. Determinants of HIV seroconversion in injection drug users during a period of rising prevalence in Vancouver. Int J STD AIDS. 1997;8:437-445.
3. Platt L, Bobrova N, Rhodes T, et al. High HIV prevalence among injecting drug users in Estonia: implications for understanding the risk environment. AIDS. 2006;20:2120-2123.
4. Rhodes T, Judd A, Mikhailova L, et al. Injecting equipment sharing among injecting drug users in Togliatti City, Russian Federation: maximizing the protective effects of syringe distribution. J Acquir Immune Defic Syndr. 2004;35:293-300.
5. Santibanez SS, Garfein RS, Swartzendruber A, et al. Update and overview of practical epidemiologic aspects of HIV/AIDS among injection drug users in the United States. J Urban Health. 2006;83:86-100.
6. Centers for Disease Control and Prevention. HIV/AIDS surveillance report, 2005. 2007;17. Available at: http://www.cdc.gov/hiv/topics|/surveillance|/ resources|/reports|/index.htm. Accessed July 17, 2007.
7. Bluthenthal RN, Kral AH, Gee L, et al. The effect of syringe exchange use on high-risk injection drug users: a cohort study. AIDS. 2000;14:605-611.
8. Des Jarlais DC, Marmor M, Paone D, et al. HIV incidence among injecting drug users in New York City syringe-exchange programmes. Lancet. 1996;348:987-991.
9. Gibson DR, Flynn NM, Perales D. Effectiveness of syringe exchange programs in reducing HIV risk behavior and HIV seroconversion among injecting drug users. AIDS. 2001;15:1329-1341.
10. Kyrychenko P. Predictors of sharing injection paraphernalia among users of the syringe exchange program: implications for HIV intervention [abstract WePeC5983]. Presented at: International Conference on AIDS; Bangkok, Thailand; 2004.
11. Wood E, Tyndall MW, Spittal PM, et al. Factors associated with persistent high-risk syringe sharing in the presence of an established needle exchange programme. AIDS. 2002;16:941-943.
12. Deren S, Estrada A, Stark M, et al. A multisite study of sexual orientation and injection drug use as predictors of HIV serostatus in out-of-treatment male drug users. J Acquir Immune Defic Syndr Hum Retrovirol. 1997;15:289-295.
13. Kral AH, Page-Shafer K, Edlin BR, et al. Persistent HIV incidence among injection drug users in San Francisco during the 1990s: results of five studies. J Acquir Immune Defic Syndr. 2004;37:1667-1669.
14. Deren S, Estrada AL, Stark M, et al. Sexual orientation and HIV risk behaviors in a national sample of injection drug users and crack smokers. Drugs Soc. 1996;9:97-108.
15. Lambert E, Normand J, Stall R, et al. Introduction: new dynamics of HIV risk among drug-using men who have sex with men. J Urban Health. 2005;82(Suppl 1):i1-i8.
16. Semple SJ, Patterson TL, Grant I. A comparison of injection and non-injection methamphetamine-using HIV positive men who have sex with men. Drug Alcohol Depend. 2004;76:203-212.
17. Celentano DD, Vlahov D, Cohn S, et al. Risk factors for shooting gallery use and cessation among intravenous drug users. Am J Public Health. 1991;81:1291-1295.
18. Maslow CB, Friedman SR, Perlis TE, et al. Changes in HIV seroprevalence and related behaviors among male injection drug users who do and do not have sex with men: New York City, 1990-1999. Am J Public Health. 2002;92:382-384.
19. Miller CL, Johnston C, Spittal PM, et al. Opportunities for prevention: hepatitis C prevalence and incidence in a cohort of young injection drug users. Hepatology. 2002;36:737-742.
20. Tyndall MW, Currie S, Spittal P, et al. Intensive injection cocaine use as the primary risk factor in the Vancouver HIV-1 epidemic. AIDS. 2003;17:887-893.
21. Wood E, Tyndall MW, Spittal PM, et al. Unsafe injection practices in a cohort of injection drug users in Vancouver: could safer injecting rooms help? CMAJ. 2001;165:405-410.
22. Wood E, Li K, Small W, et al. Recent incarceration independently associated with syringe sharing by injection drug users. Public Health Rep. 2005;120:150-156.
23. Craib KJ, Spittal PM, Wood E, et al. Risk factors for elevated HIV incidence among Aboriginal injection drug users in Vancouver. CMAJ. 2003;168:19-24.
24. Kerr T, Marsh D, Li K, et al. Factors associated with methadone maintenance therapy use among a cohort of polysubstance using injection drug users in Vancouver. Drug Alcohol Depend. 2005;80:329-335.
25. Sethi AK, Celentano DD, Gange SJ, et al. High-risk behavior and potential transmission of drug-resistant HIV among injection drug users. J Acquir Immune Defic Syndr. 2004;35:503-510.
26. Kral AH, Lorvick J, Ciccarone D, et al. HIV prevalence and risk behaviors among men who have sex with men and inject drugs in San Francisco. J Urban Health. 2005;82(Suppl 1):i43-i50.
27. Rhodes F, Deren S, Wood MM, et al. Understanding HIV risks of chronic drug-using men who have sex with men. AIDS Care. 1999;11:629-648.
28. Strathdee SA, Galai N, Safaiean M, et al. Sex differences in risk factors for HIV seroconversion among injection drug users: a 10-year perspective. Arch Intern Med. 2001;161:1281-1288.
29. Weber AE, Craib KJ, Chan K, et al. Determinants of HIV serconversion in an era of increasing HIV infection among young gay and bisexual men. AIDS. 2003;17:774-777.
30. Clatts MC, Welle DL, Goldsamt LA. Reconceptualizing the interaction of drug and sexual risk among MSM speed users: notes toward an ethnoepidemiology. AIDS Behav. 2001;5:115-130.
31. Waldorf D, Murphy S, Lauderback D, et al. Needle sharing among male prostitutes: preliminary findings of the Prospero Project. J Drug Issues. 1990;20:309-334.
32. O'Connell JM, Lampinen TM, Weber AE, et al. Sexual risk profile of young men in Vancouver, British Columbia, who have sex with men and inject drugs. AIDS Behav. 2004;8:17-23.
33. Ostrow D, McKirnan D. Prevention of substance-related high-risk sexual behavior among gay men: critical review of the literature and proposed harm reduction approach. J Gay Lesbian Med Assoc. 1997;1:97-100.
34. Clatts MC, Goldsamt L, Neaigus A, et al. The social course of drug injection and sexual activity among YMSM and other high-risk youth: an agenda for future research. J Urban Health. 2003;80(Suppl 3):iii26-iii39.
35. Des Jarlais DC, Paone D, Milliken J, et al. Audio-computer interviewing to measure risk behaviour for HIV among injecting drug users: a quasirandomised trial. Lancet. 1999;353:1657-1661.